On September 20, 2021 Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in viral and liver diseases, reported that Lawrence M. Blatt, Ph.D., MBA, Chairman and CEO of Aligos, will present at the Cantor Virtual Global Healthcare Conference being held September 27-30, 2021 (Press release, Aligos Therapeutics, SEP 20, 2021, View Source [SID1234591818]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Cantor Virtual Global Healthcare Conference
Date: Monday, September 27rd, 2021
Time: 1:20 pm to 1:50 pm Eastern Time
Presenter: Lawrence M. Blatt, Ph.D., MBA, Chairman and CEO of Aligos
Webcast: View Source
* a replay will be available following the presentation for 90 days
Please contact your Cantor Fitzgerald representative to schedule virtual one-on-one meetings with Aligos during the conference.
For more information about the Cantor Virtual Global Healthcare Conference, please refer to the Cantor Fitzgerald conference website.